The report for Global Nutrigenomics Market of Market Research Future comprises of
extensive primary research along with the detailed analysis of qualitative as well as
quantitative aspects by various industry experts, key opinion leaders to gain deeper insight
to the market and industry performance.
Neutrigenomics is the study of interaction of nutrient and genes. It studies the effect of food
and their constituents on the genes. The major factors contributing for the growth of the
market are rising diabetic and obese population, increasing applications in dermatology, and
increasing demand for the advanced diagnostic methods. According to the International
Diabetes Federation (2016), 420 million adults were suffering from diabetes which is
expected to reach 625 million by 2040. Further, as per the World Health Organization
(2014), more than 600 million adults were obese and 1.9 billion adults, were overweight.
Moreover, increasing healthcare expenditure, and government support for research &
development has fueled the market growth. However, high cost of treatment and need of
well qualified physicians may restrain the growth of market.
The Nutrigenomics Market is growing at a tremendous pace. The market is expected to grow
at the CAGR of 16.8% during the forecast period and is estimated to reach USD 17,313.5
million by 2023.
Segments:
Global Nutrigenomics Market has been segmented on the basis of products, techniques and
application. On the basis of products, the market is categorized into reagents & kits,
services. On the basis of techniques, the market is segmented into saliva, buccal swab,
blood, others. On the basis of application the market is segmented into obesity, diabetes,
anti-aging, chronic diseases.
Some of the major players in this market are: WellGen Inc. (US), Metagenics, Inc (US),
Genomix Nutrition, Inc. (US), Nutrigenomix (US), NutraGene (India), XCODE Life Sciences
Pvt. Ltd. (India), Cura Integrative Medicine (Australia)
Get Sample copy at https://www.marketresearchfuture.com/sample_request/4009 .
Regional analysis of global nutrigenomics market:
Considering the global scenario of the market, America dominates the global nutrigenomics
market owing to the presence of huge population suffering from diabetes and obesity. North
America holds the largest market share in America nutrigenomics market. According to the
Centers for Disease Control and Prevention (2015), in America approximately 9.3% of the
total America population is suffering from diabetes. Europe has the second largest market
for the nutrigenomics which is followed by Asia Pacific. Presence of well-developed
healthcare sector and high healthcare expenditure, the nutrigenomics market in Europe is
growing at a CAGR of 17%. Asia Pacific is also witnessing a rapid growth in this market
which is mainly due to rapidly increasing awareness of treatments, presence of huge
diabetic and obese population and rising healthcare expenditure. Asia Pacific nutrigenomics
market is expected to grow at a CAGR of 17.1% during the forecasted period. The Middle
East & Africa is expected to have limited growth. Middle East is dominating this market by
holding 64.3% of the Middle East & Africa market share.
Key Findings:
Obesity segment accounts for the largest market share in the global nutrigenomics
market while diabetes segment is projected to grow at a CAGR of 17.1% during the
forecast period from 2017 – 2023.
Reagents and kits segment accounts for the largest market share in the global
nutrigenomics market by products, this segment is expected to reach USD 10,138.7
in 2023
Americas market is expected to reach USD 6,316.4 by 2023
The report gives a clear picture of the current market scenario which includes historical and
projected market size in terms of value and volume, technological advancement, macro
economical and governing factors in the market. The report provides details information and